Evaluation of the Vivo Isar Stent System in Routine Clinical Practice

Inclusion Criteria:

• ≥18 years old

• Ability to provide signed informed consent form.

• Male or non-pregnant female patient (Pregnancy status to be confirmed verbally fromthe female patient of reproductive age)

• Presentation with acute coronary syndrome or chronic coronary syndrome with stableangina or angina equivalent symptoms or with a positive noninvasive test forischemia or evidence of a functionally significant coronary stenosis.

• Patient having social security number.

• Patient treated only with Vivo ISAR stent in case of single or multiple vesselstenting

Exclusion Criteria:

• Concurrent participation in another clinical trial.

• Having benefited from an angioplasty of ≤ 1 month with a stent other than Vivo ISAR.

• Planned elective surgery in next 6 months

• Cardiogenic shock/ hemodynamically unstable patients

• Concurrent medical condition with a life expectancy of less than 12 months

• History of cerebrovascular accident in the last 6 months.

• Vulnerable patient under guardianship or curatorship